HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ablative fractional laser treatment for hypertrophic scars: comparison between Er:YAG and CO2 fractional lasers.

AbstractBACKGROUND:
Nonablative fractional photothermolysis has been reported to show early promise in the treatment of hypertrophic scars, but there are few reports on ablative fractional photothermolysis for the treatment of hypertrophic scars.
AIM:
To evaluate and compare the efficacy and safety of Er:YAG fractional laser (EYFL) and CO2 fractional laser (CO2FL) for treatment of hypertrophic scars.
METHODS:
Thirteen patients with hypertrophic scars were treated with 2,940 nm EYFL, and ten were treated with 10,600 nm CO2FL. An independent physician evaluator assessed the treatment outcomes using Vancouver scar scale (VSS) and 5-point grading scale (grade 0, no improvement; grade 1, 1-25%; grade 2, 26-50%; grade 3, 51-75%; grade 4, 76-100% improvement). Patients are queried about their subjective satisfaction with the treatment outcomes.
RESULTS:
After the final treatment, average percentage changes of VSS were 28.2% for EYFL and 49.8% for CO2FL. Improvement was evident in terms of pliability, while insignificant in terms of vascularity and pigmentation. Based on physician's global assessment, mean grade of 1.8 for EYFL and 2.7 for CO2FL was achieved. Patient's subjective satisfaction scores paralleled the physician's objective evaluation.
CONCLUSION:
CO2FL is a potentially effective and safe modality for the treatment of hypertrophic scars, particularly in terms of pliability.
AuthorsJae Eun Choi, Ga Na Oh, Jong Yeob Kim, Soo Hong Seo, Hyo Hyun Ahn, Young Chul Kye
JournalThe Journal of dermatological treatment (J Dermatolog Treat) Vol. 25 Issue 4 Pg. 299-303 (Aug 2014) ISSN: 1471-1753 [Electronic] England
PMID23621348 (Publication Type: Comparative Study, Journal Article)
Topics
  • Adolescent
  • Adult
  • Child
  • Cicatrix, Hypertrophic (surgery)
  • Female
  • Humans
  • Laser Therapy
  • Lasers, Gas (therapeutic use)
  • Lasers, Solid-State (therapeutic use)
  • Male
  • Middle Aged
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: